Patents by Inventor Keiko Mizuno

Keiko Mizuno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treating inflammatory diseases with antibodies that inhibit fractalkine-CXCR1 interaction
    Patent number: 8518401
    Abstract: A therapeutic agent for an inflammatory disease comprising an antibody or a CX3CR1 antagonist that inhibits an interaction of fractalkine and CX3CR1 is provided.
    Type: Grant
    Filed: October 31, 2005
    Date of Patent: August 27, 2013
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Yoshikazu Kuboi, Toshio Imai, Miyuki Nishimura, Keiko Mizuno
  • T Cell Adhesion Molecule and Antibody Thereto
    Publication number: 20090181025
    Abstract: An object of the present invention is to provide a T cell adhesion molecule that is expressed on a dendritic cell. According to the present invention, there is provided a protein comprising the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10 or SEQ ID NO: 12.
    Type: Application
    Filed: September 29, 2006
    Publication date: July 16, 2009
    Inventors: Hideaki Ogasawara, Keiko Mizuno, Yoshihisa Arita, Miyuki Nishimura, Toshio Imai
  • Human tumor necrosis factor .alpha.specific monoclonal antibody and method for detecting human tumor necrosis factor .alpha.
    Patent number: 5360716
    Abstract: Monoclonal antibodies exhibiting specificity for human TNF-.alpha. are disclosed. The antibodies are useful for immunological purification and for measurement of said human TNF-.alpha. in immunoassays.
    Type: Grant
    Filed: February 16, 1993
    Date of Patent: November 1, 1994
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Yasukazu Ohmoto, Tsutomu Nishida, Keiko Mizuno, Satoru Nakai